3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Prostatic Neoplasms
3
Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Multiple Pulmonary Nodules
1
Multiple Myeloma
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Hodgkin Disease
1
Hepatic Malignancies
1
Head and Neck Neoplasms
1
Glioblastoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Hepatocellular
1
Cancer Diagnosis
1
Breast Cancer Metastases
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
fluciclovine F-18
2
Positron-Emission Tomography
2
Injections
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
pembrolizumab
1
ioflupane
1
idelalisib
1
aflibercept
1
Water
1
Vertical Dimension
1
Methylene Blue
1
Mammography
1
Drug Delivery Systems
1
Diagnosis, Computer-Assisted
1
Daunorubicin
1
Cytarabine
1
Control Groups
1
CPX-351
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Disease
×
Positron Emission Tomography Computed Tomography
×
Clear all
No trials found.